Axa’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36,140
Closed -$1.31M 66
2026
Q1
$1.31M Sell
36,140
-3,600
-9% -$142K 0.51% 27
2025
Q4
$1.52M Sell
39,740
-6,834
-15% -$245K 0.72% 29
2025
Q3
$1.57M Sell
46,574
-1,145,006
-96% -$35.7M 0.79% 28
2025
Q2
$37.3M Buy
1,191,580
+7,836
+0.7% +$239K 0.11% 175
2025
Q1
$34.6M Buy
1,183,744
+31,464
+3% +$820K 0.11% 184
2024
Q4
$30.3M Sell
1,152,280
-38,894
-3% -$1.03M 0.09% 210
2024
Q3
$31.1M Buy
1,191,174
+29,348
+3% +$727K 0.09% 210
2024
Q2
$29M Buy
1,161,826
+3,056
+0.3% +$81K 0.09% 214
2024
Q1
$34.3M Sell
1,158,770
-44,402
-4% -$1.28M 0.1% 199
2023
Q4
$34.7M Sell
1,203,172
-63,672
-5% -$1.7M 0.11% 188
2023
Q3
$33.5M Buy
1,266,844
+87,556
+7% +$2.49M 0.12% 186
2023
Q2
$33.9M Sell
1,179,288
-131,896
-10% -$3.75M 0.11% 200
2023
Q1
$35.4M Buy
1,311,184
+377,428
+40% +$9.68M 0.12% 197
2022
Q4
$23.7M Sell
933,756
-118,572
-11% -$2.87M 0.09% 272
2022
Q3
$22.9M Sell
1,052,328
-734,084
-41% -$16.9M 0.09% 258
2022
Q2
$41.4M Sell
1,786,412
-29,232
-2% -$636K 0.15% 154
2022
Q1
$36.3M Sell
1,815,644
-60,520
-3% -$1.27M 0.1% 231
2021
Q4
$45M Sell
1,876,164
-250,168
-12% -$5.56M 0.12% 207
2021
Q3
$47.2M Sell
2,126,332
-6,056
-0.3% -$143K 0.13% 190
2021
Q2
$48.7M Buy
2,132,388
+75,572
+4% +$1.77M 0.14% 176
2021
Q1
$46.8M Sell
2,056,816
-248,120
-11% -$5.56M 0.14% 180
2020
Q4
$53.3M Sell
2,304,936
-1,152,640
-33% -$24.2M 0.17% 141
2020
Q3
$69.3M Buy
3,457,576
+1,336,920
+63% +$26.4M 0.25% 91
2020
Q2
$36.8M Buy
2,120,656
+348,920
+20% +$5.7M 0.14% 166
2020
Q1
$24.9M Sell
1,771,736
-24,852
-1% -$399K 0.12% 194
2019
Q4
$28.5M Buy
1,796,588
+3,076
+0.2% +$45.2K 0.12% 220
2019
Q3
$26M Buy
1,793,512
+158,144
+10% +$2.4M 0.1% 248
2019
Q2
$26.1M Sell
1,635,368
-17,784
-1% -$268K 0.1% 257
2019
Q1
$22.6M Sell
1,653,152
-59,636
-3% -$850K 0.09% 275
2018
Q4
$21.1M Sell
1,712,788
-170,836
-9% -$2.32M 0.09% 264
2018
Q3
$27.4M Sell
1,883,624
-2,521,880
-57% -$37.9M 0.1% 243
2018
Q2
$63.1M Buy
4,405,504
+323,048
+8% +$4.36M 0.24% 118
2018
Q1
$58.4M Buy
4,082,456
+254,000
+7% +$3.97M 0.23% 114
2017
Q4
$60.6M Buy
3,828,456
+175,836
+5% +$2.63M 0.24% 120
2017
Q3
$50.5M Sell
3,652,620
-304,456
-8% -$4.1M 0.22% 135
2017
Q2
$49.1M Sell
3,957,076
-54,772
-1% -$660K 0.22% 130
2017
Q1
$46.3M Sell
4,011,848
-576,580
-13% -$6.44M 0.21% 145
2016
Q4
$50.9M Buy
4,588,428
+254,292
+6% +$2.91M 0.24% 123
2016
Q3
$53M Sell
4,334,136
-16,800
-0.4% -$218K 0.23% 129
2016
Q2
$58.3M Sell
4,350,936
-530,400
-11% -$6.4M 0.26% 114
2016
Q1
$54.3M Buy
4,881,336
+16,656
+0.3% +$185K 0.24% 117
2015
Q4
$60.4M Sell
4,864,680
-231,372
-5% -$2.79M 0.26% 108
2015
Q3
$57.4M Sell
5,096,052
-2,033,472
-29% -$23.8M 0.24% 114
2015
Q2
$79.6M Buy
7,129,524
+4,910,652
+221% +$54.8M 0.32% 82
2015
Q1
$25.6M Sell
2,218,872
-362,400
-14% -$3.79M 0.11% 221
2014
Q4
$23.3M Sell
2,581,272
-356,400
-12% -$3.07M 0.09% 238
2014
Q3
$22.4M Buy
2,937,672
+1,365,672
+87% +$8.96M 0.1% 238
2014
Q2
$9.3M Sell
1,572,000
-456,000
-22% -$2.6M 0.04% 416
2014
Q1
$11.7M Hold
2,028,000
0.05% 347
2013
Q4
$11.5M Buy
2,028,000
+24,000
+1% +$118K 0.05% 351
2013
Q3
$8.73M Hold
2,004,000
0.04% 389
2013
Q2
$10.1M Buy
+2,004,000
New +$9.41M 0.05% 331

Other funds holding MNST

Axa's MNST Position: Q2 2026 in Review

Axa sold out of Monster Beverage (MNST) in Q2 2026, closing a stake of 36,140 shares — an estimated $1.31M sold.

Axa first reported a position in MNST in Q2 2013 and held it in 52 quarters. The position peaked at $79.6M in Q2 2015. 1,369 funds tracked by Wall St. Rank hold MNST as of Q2 2026.

  • Axa reported no remaining Monster Beverage position as of Q2 2026 after selling out during the quarter.
  • Axa sold 36,140 Monster Beverage shares in Q2 2026, an estimated $1.31M.
  • Axa first reported a position in Monster Beverage in Q2 2013 and held it in 52 quarters.
  • Axa's Monster Beverage position peaked at $79.6M in Q2 2015.
  • 1,369 funds tracked by Wall St. Rank held Monster Beverage as of Q2 2026.

Based on Axa's 13F filing for Q2 2026, filed 14 Aug 2026.